Hubei Biocause Pharmaceutical Capital Reinvestment Ratio
Hubei Biocause Pharmaceutical capital reinvestment ratio. Hubei Biocause Pharmaceutical (000627) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥276.06 Million) in capital expenditures (CN¥10.51 Million). Check Hubei Biocause Pharmaceutical (000627) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hubei Biocause Pharmaceutical (2001–2023)
Capital reinvestment ratio of Hubei Biocause Pharmaceutical from 2001 to 2023. This chart tracks Hubei Biocause Pharmaceutical's Capital Reinvestment Ratio across 16 annual periods. Also explore Hubei Biocause Pharmaceutical annual equity growth to track the company's year-over-year net asset growth rate.
Hubei Biocause Pharmaceutical Capital Reinvestment Ratio by Year (2001–2023)
Hubei Biocause Pharmaceutical capital reinvestment ratio by year from 2001 to 2023. For the full cash flow conversion analysis, see Hubei Biocause Pharmaceutical cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | CN¥9.53 Billion | CN¥67.53 Million | ▼ -60.5% |
| 2022 | 0.02x | CN¥7.52 Billion | CN¥135.06 Million | ▼ -73.9% |
| 2021 | 0.07x | CN¥4.17 Billion | CN¥287.13 Million | ▲ +361.4% |
| 2020 | 0.01x | CN¥21.42 Billion | CN¥319.51 Million | ▼ -40.5% |
| 2019 | 0.03x | CN¥28.60 Billion | CN¥717.10 Million | ▲ +36.8% |
| 2018 | 0.02x | CN¥14.98 Billion | CN¥274.67 Million | ▼ -99.0% |
| 2017 | 1.80x | CN¥431.58 Million | CN¥778.95 Million | ▲ +63.8% |
| 2013 | 1.10x | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥37.30 Million | CN¥31.47 Million | — |